Trial Information

Summary: A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.

Status: No longer recruiting

Protocol Number: ML20055

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: An open label study to evaluate the effect of CellCept in combination wth cyclosporine A and steroids on renal function and the prevention of acute rejection in heart transplant patients.

Brief Summary: This study will investigate the efficacy and safety of CellCept (1.5-2g/day po), in combination with a standard care regimen of cyclosporine A (trough level 150-200ng/mL) and steroids, in patients receiving a heart transplant. The anticipated time on study treatment is 3-12 months, and the target sample size is <100 individuals. Target sample size is 36.

Study Phase: III

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Non-Randomized
• Masking: Open Label
• Control: Uncontrolled
• Assignment: Single Group
• Endpoints: Safety/Efficacy

Study Type:

Condition: Heart Transplantation

Intervention Type: Drug

Intervention Name: mycophenolate mofetil[CellCept]

Primary Outcome: 1. Renal function (calculated creatinine clearance at 24 weeks post-transplant), incidence of acute rejection or HDC, or graft loss, up to 12 months post-transplant.

Key Secondary Outcomes: 1. Efficacy: incidence of malignancies; incidence of infections; AEs.

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: August, 2006

Trial Registration Date: 07/19/2006

Date Last Updated: 08/18/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 20, 2008 at 2:16:14 PM